Skip to main
IRD
IRD logo

Opus Genetics (IRD) Earnings Dates & Reports

Opus Genetics (IRD) Most Recent Earnings

Report DateMay 15, 2025
Period EndingQ1 2025
Est. EPS-$0.29
Actual EPS-$0.24
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Opus Genetics (IRD) Earnings per Share (EPS) History

Signup for full access
Browse free

Opus Genetics (IRD) Latest Earnings

The value each IRD share was expected to gain vs. the value each share gained.

Opus Genetics (IRD) reported its most recent earnings on May 15, 2025 for Q1 2025, posting earnings per share (EPS) of -$0.24. This exceeded analysts' expectations of -$0.29 by 17.24%, marking a Beat.

For comparison, Opus Genetics reported EPS of $0 in the same quarter last year.

The company is expected to announce its next earnings report on 08/15/2025, with analysts projecting an EPS of -$0.26.

Opus Genetics (IRD) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q2 2025Aug 15, 2025
-$0.26Next earnings call Aug. 15, 2025
Q1 2025May 15, 2025
-$0.29-$0.24-17.24%
DeckReportListen
Q4 2024Mar 31, 2025
-$1.27
Q3 2024Nov 12, 2024
-$0.29

Opus Genetics (IRD) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Opus Genetics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
May 15, 2025
Mar 31, 2025
Nov 12, 2024

Opus Genetics (IRD) Earnings FAQs

Opus Genetics (IRD) last reported earnings on May 15, 2025 for Q1 2025, posting an EPS of -$0.24, which Beat the estimate of -$0.29 by 17.24%.

For Q1 2025, Opus Genetics (IRD) reported an EPS of -$0.24, exceeding analysts' estimate of -$0.29 by 17.24%.

For Q1 2025, Opus Genetics (IRD) Beat expectations with an actual EPS of -$0.24 vs. an estimated EPS of -$0.29.

Following the last earnings report on May 15, 2025, Opus Genetics (IRD)'s stock price moved — from — to —.

The next Opus Genetics (IRD) earnings call is scheduled for Aug. 15, 2025, where executives will discuss financial results and outlook.

Opus Genetics (IRD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.